Kusajili – Clinical trials directory

Result of your search per sponsor: Michel Kalamarides, Professor

Woman and Man Max 99 years
Michel Kalamarides, Professor Update Il y a 5 ans

Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients The purpose of the study is to determine if RAD001 treatment will shrink or slow the growth of the vestibular schwannoma(s) in Neurofibromatosis 2 (NF2) patients.

Country None
organs None
Specialty None

Closed trial

More information